Lesson 8 · How does the healthcare system work?
Is the healthcare system working? Role, access and future opportunities
“Assess the effectiveness” is a command word, not a topic. It requires a criterion, evidence against that criterion, and a judgement — and the criterion is the part students skip. A system can be highly effective at treating illness and poor at preventing it, excellent on average and inequitable in distribution, and both verdicts can be defended with the same data.
Before reading on: what would you have to measure to decide whether a country's healthcare system is working?
List three things. Then ask yourself whether any of your three would notice a system that treats people brilliantly once they arrive and is unreachable for a tenth of the population.
- Describe the role of the healthcare system, including the parts of it that are not treatment.
- Assess equity of access, and distinguish access from availability.
- Identify future opportunities for the system, specifically in rural and remote locations, for Aboriginal and Torres Strait Islander Peoples, and for individuals with disability.
- Use an explicit criterion when assessing effectiveness, rather than asserting a verdict.
- Hold two true verdicts at once: strong on average, uneven in distribution.
- Healthcare system — the organisations, workforce, funding and regulation through which a population's health services are delivered.
- Primary healthcare — the first point of contact, typically general practice, pharmacy, community health and allied health; where most care happens and where most prevention is possible.
- Secondary and tertiary care — specialist and hospital services, usually reached by referral.
- Access — whether a person can actually obtain care when they need it, which depends on cost, distance, time, language, culture and acceptability, not only on a service existing.
- Equity of access — that people with the same need can obtain the same care, regardless of who they are or where they live.
- Effectiveness — how well the system achieves what it is for; meaningless until what it is for has been stated.
- Efficiency — the outcome achieved for the resources used; a different question from effectiveness, and often confused with it.
- Continuity of care — being seen over time by someone who knows your history, which improves outcomes in chronic disease more than almost anything else in primary care.
Six functions, and only the first is what most people picture.
- Treatment of illness and injury. The visible role: emergency, hospital, specialist and general practice care.
- Prevention and early detection. Immunisation, screening, risk-factor management, health promotion. This is where the largest long-run gains are, and where the smallest share of spending sits.
- Management of chronic conditions. Increasingly the system's main workload, and the function it was least designed for — because the system was built around episodes and chronic conditions are not episodes.
- Rehabilitation and support for function. Restoring what illness or injury removed, so that treatment translates into a life.
- Protecting people from financial hardship. A health system that cures a person and impoverishes them has not done its job. This is why the funding arrangements in the next lessons are part of the system, not an accounting detail.
- Surveillance, regulation and public health. Monitoring disease, controlling outbreaks, regulating medicines and safety, and maintaining the data on which everything in this module depends.
Name the role before you assess it. An answer that assesses a treatment system against treatment outcomes will always conclude that the system is effective, because it has quietly chosen the criterion that flatters it.
Quick check: Why must the role of the healthcare system be stated before its effectiveness is assessed?
Judge the system against each of its functions in turn. The verdicts differ, which is the finding.
Where it performs strongly
- Treatment and survival. Outcomes for major conditions compare well internationally, and avoidable mortality is better than the OECD average.
- Universal coverage of core services. Cost is much less often an absolute barrier to seeing a doctor or being admitted to hospital than in systems without universal arrangements.
- Medicines. Subsidy keeps most essential medicines affordable, which matters most for the chronic conditions that need lifelong treatment.
- Public health capability. Immunisation coverage, communicable disease control and long-run policy success in tobacco.
Where it performs less well
- Equity of access. Outcomes still track remoteness, socioeconomic position and Aboriginal and Torres Strait Islander status, which is the clearest evidence that access is not equal.
- Prevention. A small share of spending, and a system that pays for activity rather than for illness avoided.
- Chronic and complex care. Funded and organised around episodes and single conditions, so people with several conditions are managed in fragments.
- Coverage gaps. Dental care, and much psychological and allied health care, sit largely outside universal arrangements, so out-of-pocket cost operates as a barrier there.
- Fragmentation between funders. Divided federal and state responsibility creates seams, and people fall through the seams.
So the honest assessment has two halves: the Australian healthcare system is effective at treating illness for most of the population, and is less effective at preventing illness and at reaching everyone equally. Both halves are needed. An answer with only the first is a brochure; an answer with only the second is a complaint.
One more distinction markers reward: effectiveness is not efficiency. A system can achieve good outcomes wastefully, or poor outcomes cheaply. Australia's issue is not principally that it spends too much, but that the spending is weighted toward the functions with the smallest remaining gains.
True or false: A healthcare system can be judged effective at treatment and ineffective at prevention at the same time, because effectiveness is judged separately against each function.
Access is not the same as availability. A service can exist and be unreachable. Five dimensions, and a service has to clear all five for a given person.
- Availability. Does the service exist within reach, with capacity to see you? Fails where there is no local practitioner, or where the waiting list is longer than the illness.
- Affordability. What does it cost after any subsidy, including travel, time off work and medicines? This is the dimension that produces the dental and specialist gaps.
- Accessibility. Can you physically get there and physically use it? Transport, opening hours, buildings, communication formats.
- Acceptability. Would you use it? Cultural safety, language, gender of practitioner, stigma, past experience. A service that is free and nearby is not accessed if people expect to be treated badly in it.
- Appropriateness. Does it meet the need you actually have? A service that treats the acute episode and not the underlying condition has been accessed and has not helped.
These dimensions are conjunctive, not additive. Passing four and failing one means no care. This is why single-barrier programs underperform, and it is the same compounding argument as Lesson 3.
Evidence that access is unequal in Australia does not need a survey: it is visible in the outcome data. If access were equal, outcomes would not track postcode as reliably as they do. Persistent outcome gradients by remoteness and socioeconomic position are the access evidence.
Fill the gaps. Whether a person would actually be willing to use a service, given culture, language and past experience, is the dimension of . Being seen over time by someone who knows your history is called of care.
The syllabus names three: rural and remote locations, Aboriginal and Torres Strait Islander Peoples, and individuals with disability. Each has opportunities that are specific to it, and one that all three share.
- In rural and remote locations. Telehealth for consultation and specialist review; expanded scope for rural generalists, nurse practitioners and pharmacists so that fewer problems require a referral; rural training pathways that produce clinicians who stay; better retrieval and transfer; and pooled funding so a small population can still support a service.
- For Aboriginal and Torres Strait Islander Peoples. Expanding community-controlled health services and their share of funding; growing the Aboriginal and Torres Strait Islander health workforce; embedding cultural safety in mainstream services and measuring it from the patient's side; and shifting decisions about service design to communities.
- For individuals with disability. Removing physical and communication barriers; training clinicians to avoid attributing every new symptom to an existing disability; joining up the health system with disability support so people are not caught between two funders; and including people with disability in mainstream prevention and screening programs that currently reach them less.
The shared opportunity is continuity. In all three settings, the largest available gain is not a new treatment; it is someone who knows the person, follows them over time and coordinates the pieces. Continuity improves chronic disease outcomes, reduces avoidable admissions and is exactly what a fragmented, episode-funded system does worst.
Two general opportunities worth naming because they cut across all three: shifting the funding model from paying for episodes toward paying for continuing care of a person, and designing services with the people who use them, which is the single most reliable predictor of whether a service is used.
Two truths and a lie. One of these statements about access is false. Find it.
Four moves, in order. They work for any “assess the effectiveness” question in this course.
- State the criterion. “Effectiveness is judged here against the system's stated functions: treatment, prevention, chronic care, rehabilitation, financial protection and public health.” One sentence, and it changes the entire answer.
- Give evidence on both sides. Strong on treatment outcomes and universal coverage; weaker on prevention, chronic care and equity of access. Use trends and mechanisms, not figures.
- Explain the trade-off rather than listing. Why is prevention underfunded? Because the system pays for activity, benefits appear beyond the funding cycle, and prevented illness is invisible. That explanation is worth more than three more examples.
- Reach a judgement with a qualifier. “Effective at treating illness for most Australians; substantially less effective at preventing illness and at reaching particular populations — and the second is the more consequential, because the groups it misses are the groups with the greatest need.”
The most common failure is a list of features with the word “effective” attached to the end. The second most common is a verdict with no criterion, which cannot be argued with and therefore cannot be credited.
Activities · assess with a criterion
For each, name the access dimension that failed and one change that would fix it.
A patient is bulk-billed for the consultation but does not fill the prescription, because the medicine is unsubsidised and the pharmacy is a bus trip away.
A woman does not return to a clinic after a previous visit in which she was spoken about rather than to, in front of her children.
A man attends emergency four times in a year for the same chronic condition and is treated and discharged each time.
A town's only general practitioner retires and the position is unfilled for a year.
Match each function of the healthcare system to what it is for.
- Prevention
- Chronic condition management
- Financial protection
- Surveillance and regulation
- Stopping illness occurring, or finding it before symptoms
- Keeping a long-term condition stable, over years rather than episodes
- Ensuring that being treated does not impoverish the patient
- Monitoring disease, controlling outbreaks and regulating medicines and safety
Write a four-paragraph assessment of the effectiveness of Australia's healthcare system, using the four moves from card 08: criterion, evidence both ways, an explained trade-off, and a qualified judgement.
Constraint: no statistics. If you find yourself wanting one, write the trend it would have illustrated instead.
Lock it in. In one sentence, explain why a service that exists is not the same as a service that is accessible.
Assess the effectiveness of the healthcare system in Australia, with reference to its role and equity of access.
Assess asks for a judgement of value or quality against criteria — the same obligation as Evaluate. The stem supplies two of the criteria for you: the system's role, and equity of access.
Plan: take the criteria from the stem, run the evidence both ways, then commit to a judgement.
The system will be assessed against three criteria: whether it fulfils its role of providing treatment and preventive care, whether access is equitable across the population, and whether it is sustainable at its current cost.
Against the first criterion the system performs strongly. Medicare provides universal access to medical services and public hospital treatment free at the point of care, the Pharmaceutical Benefits Scheme caps the cost of essential medicines, and Australia achieves life expectancy among the highest in the OECD at close to average expenditure — which is evidence of efficient conversion of resources into outcomes.
Against equity of access the performance is weaker. Bulk-billing rates vary by location and have fallen, so out-of-pocket costs increasingly determine whether care is sought, and gap payments for specialist, dental and allied health services place them out of reach for lower-income Australians. Dental care sits largely outside Medicare altogether. Geographic maldistribution of the workforce means rural and remote Australians wait longer and travel further, and Aboriginal and Torres Strait Islander Peoples face additional barriers where services are not culturally safe.
Against sustainability, the system is under compounding pressure: an ageing population, rising chronic disease prevalence and increasingly expensive technologies raise costs, while expenditure remains weighted toward treatment rather than the prevention that would reduce future demand.
On balance the Australian healthcare system is highly effective at treatment and only partially effective at equitable access. Universality secures a strong national average, but the services excluded from it — dental, allied health and much specialist care — are precisely those where cost determines use, so the system's weakness is concentrated exactly where its coverage stops.
The Australian healthcare system will be assessed against whether it fulfils its role of providing treatment and preventive care, whether access is equitable, and whether it is sustainable at current cost. Against the first it performs strongly: Medicare provides universal access to medical services and public hospital treatment free at the point of care, the Pharmaceutical Benefits Scheme caps the cost of essential medicines, and Australia achieves life expectancy among the highest in the OECD at close to average expenditure, evidencing efficient conversion of resources into outcomes. Against equity the performance is weaker. Bulk-billing rates vary by location and have fallen, so out-of-pocket costs increasingly determine whether care is sought; gap payments place specialist, dental and allied health services out of reach for lower-income Australians, with dental care largely outside Medicare altogether; geographic maldistribution of the workforce means rural and remote Australians wait longer and travel further; and Aboriginal and Torres Strait Islander Peoples face further barriers where services are not culturally safe. Against sustainability the system faces compounding pressure from an ageing population, rising chronic disease and costlier technologies, while expenditure remains weighted toward treatment rather than the prevention that would reduce future demand. On balance the system is highly effective at treatment and only partially effective at equitable access: universality secures a strong national average, but the services excluded from it are precisely those where cost determines use, so its weakness is concentrated exactly where its coverage stops.
Discuss the tension between funding treatment and funding prevention in the Australian healthcare system.
Discuss asks you to put forward the arguments for and against an issue. Unlike Evaluate it does not demand a single verdict, but it does demand that you reach an informed position rather than trailing off.
Plan: define the issue, argue one side, argue the other, name the tension honestly, then take an informed position.
The issue is one of allocation. Health funding is finite, and money spent treating existing illness cannot simultaneously be spent preventing future illness, so the two compete for the same budget on very different timescales.
Treatment has an overwhelming claim on the budget because its need is immediate, identified and unavoidable. A person presenting with a heart attack cannot be deferred, the beneficiary is a specific identifiable individual, and the political cost of visible unmet need — ambulance ramping, elective surgery waiting lists — is immediate and concentrated. Treatment spending also has a certain effect, whereas prevention's effect is probabilistic.
Prevention has the stronger claim on long-run efficiency. Chronic conditions driven by modifiable risk factors dominate the burden of disease, and population measures such as tobacco control, immunisation and screening avert far more disease per dollar than treating the same conditions later. Prevention also acts on inequity, since it reduces exposure across a whole population rather than requiring individuals to access a service.
The tension is structural rather than a matter of poor judgement. Prevention's benefits accrue over decades and to people who never know they were helped, while its costs fall in the present budget; treatment's costs and benefits both fall now and on identifiable people. Any government facing an electoral cycle shorter than the payback period therefore faces a systematic incentive to underfund prevention.
The defensible position is not that prevention should replace treatment, which is impossible, but that prevention's share should be protected from the annual pressure of acute demand — for example through dedicated, longer-cycle funding — because otherwise the more urgent claim will always displace the more efficient one.
The issue is one of allocation: health funding is finite, so money spent treating existing illness cannot simultaneously prevent future illness, and the two compete for the same budget on very different timescales. Treatment has an overwhelming immediate claim, because its need is identified and unavoidable, the beneficiary is a specific individual, the political cost of visible unmet need is concentrated, and its effect is certain rather than probabilistic. Prevention has the stronger long-run claim, since chronic conditions driven by modifiable risk factors dominate the burden of disease and population measures such as tobacco control, immunisation and screening avert far more disease per dollar than treating those conditions later, while also reducing inequity by lowering exposure across a whole population rather than requiring individuals to access a service. The tension is structural rather than a failure of judgement: prevention's benefits accrue over decades to people who never know they were helped while its costs fall in the present budget, whereas treatment's costs and benefits both fall now on identifiable people, so a government facing an electoral cycle shorter than the payback period has a systematic incentive to underfund prevention. The defensible position is therefore not that prevention should replace treatment, which is impossible, but that its share should be insulated from the annual pressure of acute demand through dedicated longer-cycle funding, because otherwise the more urgent claim will always displace the more efficient one.
Return to card 01. You listed three things you would measure. Check them against the five access gates: how many of your three would have noticed a failure at acceptability or appropriateness? Most people's first three measures see only availability and outcomes, which is exactly why access problems persist while systems report good results.
Multiple choice · 5 questions
MC 1. Which best distinguishes effectiveness from efficiency?
- A. Effectiveness concerns cost; efficiency concerns outcomes
- B. Effectiveness is whether the purpose is achieved; efficiency is the outcome achieved for the resources used
- C. They are alternative words for the same measurement
- D. Effectiveness applies to hospitals and efficiency to primary care
MC 2. A free clinic is open nearby, and members of a community do not use it after poor previous experiences. The access dimension that has failed is:
- A. availability
- B. affordability
- C. acceptability
- D. appropriateness
MC 3. Which function of the healthcare system receives the smallest share of Australian health spending relative to the long-run gains available from it?
- A. Treatment of illness and injury
- B. Prevention and early detection
- C. Hospital care
- D. Pharmaceutical supply
MC 4. The strongest available evidence that access to healthcare in Australia is not equal is:
- A. the total number of hospitals in the country
- B. that health outcomes continue to track remoteness and socioeconomic position
- C. the proportion of the population with private health insurance
- D. the number of medical graduates each year
MC 5. Across rural and remote settings, Aboriginal and Torres Strait Islander health, and disability, the shared future opportunity identified in this lesson is:
- A. building more hospitals
- B. continuity — someone who knows the person, follows them over time and coordinates their care
- C. increasing the number of specialist referrals
- D. raising private health insurance participation
Short answer · exam style
SA 1. Understand Band 4 Describe the role of the healthcare system in Australia, referring to at least three of its functions. (4 marks)
SA 2. Analyse Band 5 Analyse equity of access to the healthcare system in Australia, referring to more than one dimension of access. (5 marks)
SA 3. Evaluate Band 6 Assess the effectiveness of the healthcare system in Australia. In your answer, refer to future opportunities for the system. (6 marks)
📖 Comprehensive answers (click to reveal)
Multiple choice: 1 → B. 2 → C. 3 → B. 4 → B. 5 → B.
Activity 1 model answers: 1 → Affordability, compounded by accessibility. Fix: subsidise the medicine, or supply it at the point of care; a consultation that ends in an unfilled prescription has not delivered treatment. 2 → Acceptability. Fix: cultural safety training, employment of community health workers, and a complaints process the patient believes will be acted on — measured from the patient's side, not the service's. 3 → Appropriateness. Fix: a coordinated chronic care plan with a regular provider; repeated emergency attendance for one chronic condition is a system telling you it is treating episodes and not the person. 4 → Availability. Fix: rural training pathways, recruitment and retention incentives, expanded scope for nurse practitioners and pharmacists, and telehealth as an interim bridge.
SA 1 (4 marks): A clear statement of purpose beyond treatment [1]. Three functions described with what each is for, from: treatment; prevention and early detection; chronic condition management; rehabilitation and support for function; protection from financial hardship; surveillance, regulation and public health [3]. Naming without explaining earns half marks.
SA 2 (5 marks): Access defined as being able to obtain care when needed, not merely a service existing [1]. At least three dimensions named and explained — availability, affordability, accessibility, acceptability, appropriateness [2]. Australian evidence used: outcomes continue to track remoteness, socioeconomic position and Aboriginal and Torres Strait Islander status, and dental and psychological care sit largely outside universal coverage so cost operates as a barrier there [1]. The analytical point: the dimensions are conjunctive, so failing one is failing all, which explains why single-barrier programs underperform for people facing several barriers [1].
SA 3 (6 marks): An explicit criterion stated before any verdict [1]. Evidence of effectiveness: strong treatment outcomes and avoidable mortality better than the OECD average, universal coverage of core services, subsidised medicines, and public health capability [1]. Evidence of limitation: prevention underfunded, chronic and complex care fragmented by episode-based funding, coverage gaps in dental and psychological care, and persistent inequity of access [2]. Future opportunities referenced: telehealth, expanded scope of practice and rural training pathways in rural and remote settings; expanded community control, workforce and cultural safety for Aboriginal and Torres Strait Islander Peoples; removing physical, communication and diagnostic barriers for people with disability; and continuity as the gain shared across all three [1]. Judgement with a qualifier: effective at treatment for most Australians, less effective at prevention and at reaching particular populations, and the second matters more because the populations it misses are those with the greatest need [1].
Carry two things forward. The five access gates will be used again in every remaining lesson of this inquiry question, and the four assessment moves — criterion, evidence both ways, explained trade-off, qualified judgement — work on any “assess” or “evaluate” question in the course.
The next lesson answers a question this one leaves open: if the system is fragmented between funders, who exactly is responsible for what, and how are they supposed to work together?
Mark lesson as complete
Tick when you've finished the practice and review.